Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Sarcoma 1Head & Neck 1Breast 1

Conditions

Sarcoma 2Lung Neoplasms 2Head and Neck Neoplasms 2Melanoma 1Glioma 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Cyclophosphamide 7pembrolizumab 6Radiosurgery 6Specimen Handling 5Nivolumab 5Ifosfamide 5fludarabine phosphate 4Mycophenolic Acid 4Granulocyte Colony-Stimulating Factor 4Etoposide 4Busulfan 4Sunitinib 3Sirolimus 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Melphalan 3Magnetic Resonance Spectroscopy 3Filgrastim 3Cyclosporine 3Cryosurgery 3Carboplatin 3trastuzumab deruxtecan 2tislelizumab 2sargramostim 2pazopanib 2fludarabine 2etoposide phosphate 2cabozantinib 2Whole-Body Irradiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × AH 111585 × Sarcoma × Clear all
NCT00918281 2014-06-09

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

GE Healthcare

Phase 2 Completed
70 enrolled 9 charts
BreastGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Head and Neck Neoplasms, Lung Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡